Andrea Piacquadio
© Credits

Influenza seasonal

    Overview

    Seasonal influenza is an acute respiratory infection caused by influenza viruses which circulate in all parts of the world. It represents a year-round disease burden. It causes illnesses that range in severity and sometimes lead to hospitalization and death.

    Most people recover from fever and other symptoms within a week without requiring medical attention. However, influenza can cause severe illness or death, particularly among high risk groups including the very young, the elderly, pregnant women, health workers and those with serious medical conditions.

    In temperate climates, seasonal epidemics occur mainly during winter, while in tropical regions, influenza may occur throughout the year, causing outbreaks more irregularly.

    Symptoms

    Seasonal influenza is characterized by a sudden onset of fever, cough (usually dry), headache, muscle and joint pain, severe malaise (feeling unwell), sore throat and a runny nose. The cough can be severe and can last two or more weeks.

    Treatment

    For patients that are not in a high risk group, treatment focuses on relieving symptoms of influenza such as fever. Patients that are known to be in a group at high risk for developing severe or complicated illness should seek medical attention and should be treated with antiviral drug as soon as possible.

    News

    All →

    Publications

    All →
    Best practices for the design, implementation, reporting and analysis of participatory surveillance for influenza-like illness

    Epidemiological information on influenza comes from multiple sources. Participatory surveillance for influenza and influenza-like illness (ILI) is one...

    Status of influenza in the WHO South-East Asia Region – 2022

    Successful implementation of the Global Influenza Strategy (2019–2030), PIP framework, and End-toEnd Integration of SARS-CoV-2 and Influenza Sentinel...

    Pandemic influenza preparedness framework: partnership contribution high-level implementation plan III 2024-2030 

    The Pandemic Influenza Preparedness (PIP) Framework's Partnership Contribution (PC) High-Level Implementation Plan III (HLIP III) outlines the...

    Summary report on the WHO workshop on estimation of respiratory syncytial virus (‎RSV)‎ disease burden based on RSV surveillance of Global Influenza Surveillance and Response System, Geneva, Switzerland, 21-23 June 2023

    This report summarizes the proceedings from the “WHO workshop on estimation of respiratory syncytial virus (RSV) disease burden based on RSV surveillance...